Home Insights Project Asprin

Project Asprin

By Ensors Team
18th Jun 2014


Our client was a venture capital firm with a history of investing in pharmaceuticals, vaccines and medical devices. In this instance, they acquired a pharmacy business.

What Ensors did to achieve the deal

Ensors acted as exclusive advisor to the purchaser, providing due diligence and forecasts of the target company’s financial performance. Thus, enabling the client  to complete the acquisition and add the company to their growing portfolio.